Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats

Tissue Engineering - Part A

Volumn 18, Issue 17-18, 2012, Pages 1793-1803

  Fu, Wei Li ^a,b   Zhang, Ji Ying ^a   Fu, Xin ^a   Duan, Xiao Ning ^a   Leung, Kevin Kar Ming ^a   Jia, Zhu Qing ^c   Wang, Wei Ping ^c   Zhou, Chun Yan ^c   Yu, Jia Kuo ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b SICHUAN UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BONE; CELL DEATH; CENTRIFUGATION; FLOWCHARTING; NONINVASIVE MEDICAL PROCEDURES; RATS; TISSUE; TISSUE ENGINEERING;

ADIPOGENIC; ALTERNATIVE SOURCE; BIOLOGICAL CHARACTERISTIC; BLOOD CIRCULATION; BONE MARROW; CELL EXPANSION; CELL SURFACE MARKER; CELL THERAPY; CELLULAR SENESCENCE; CHONDROGENIC; COMPARATIVE STUDIES; DENSITY GRADIENT CENTRIFUGATION; GRANULOCYTE-COLONY STIMULATING FACTOR; IN-VITRO; INDUCED APOPTOSIS; KARYOTYPE ANALYSIS; LONG-TERM CULTURE; MEDULLARY CANALS; MESENCHYMAL STEM CELL; OSTEOGENIC; PERIPHERAL BLOOD;

CELL CULTURE;

RATTUS;

HYDROGEN PEROXIDE; LIPOCORTIN 5; PROPIDIUM IODIDE;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD CELL; BONE MARROW CELL; CELL ADHESION; CELL AGING; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; IMMUNOPHENOTYPING; KARYOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; NICK END LABELING; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANNEXIN A5; APOPTOSIS; BLOOD CELLS; BONE MARROW CELLS; CELL ADHESION; CELL AGING; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CELLS, CULTURED; HYDROGEN PEROXIDE; IMMUNOPHENOTYPING; IN SITU NICK-END LABELING; KARYOTYPING; MESENCHYMAL STROMAL CELLS; PROPIDIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867014804     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0530     Document Type: Article

References (45)

1. Bernardo, M.E., Pagliara, D., and Locatelli, F. Mesenchymal stromal cell therapy: a revolution in regenerative medicine? Bone Marrow Transplant 47, 164, 2012.
2. Shao, Z., Zhang, X., Pi, Y., Wang, X., Jia, Z., Zhu, J., Dai, L., Chen, W., Yin, L., Chen, H., Zhou, C., and Ao, Y. Poly-caprolactone electrospun mesh conjugated with an MSC affinity peptide for MSC homing in vivo. Biomaterials 33, 3375, 2012.
3. Caplan, A.I. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 11, 1198, 2005.
4. Seggewiss, R., and Einsele, H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 115, 3861, 2010.
5. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A., and Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41, 2002.
6. Jurgens, W.J.F.M., van Dijk, A., Doulabi, B.Z., Niessen, F.B., Ritt, M.J.P.F., van Milligen, F.J., and Helder, M.N. Freshly isolated stromal cells from the infrapatellar fat pad are suitable for a one-step surgical procedure to regenerate cartilage tissue. Cytotherapy 11, 1052, 2009.
7. Jackson, W.M., Nesti, L.J., and Tuan, R.S. Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther 10, 505, 2010.
8. Nekanti, U., Rao, V.B., Bahirvani, A.G., Jan, M., Totey, S., and Ta, M. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev 19, 117, 2010.
9. You, Q., Tong, X., Guan, Y., Zhang, D., Huang, M., Zhang, Y., and Zheng, J. The biological characteristics of human third trimester amniotic fluid stem cells. J Int Med Res 37, 105, 2009.
10. Fan, X.B., Liu, T.Q., Liu, Y., Ma, X.H., and Cui, Z.F. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design. Biotechnol Progr 25, 499, 2009.
11. Patel, A.N., Park, E., Kuzman, M., Benetti, F., Silva, F.J., and Allickson, J.G. Multipotent menstrual blood stromal stem cells: Isolation, characterization, and differentiation. Cell Transplant 17, 303, 2008.
12. Perdikogianni, C., Dimitriou, H., Stiakaki, E., Martimianaki, G., and Kalmanti, M. Could cord blood be a source of mesenchymal stromal cells for clinical use? Cytotherapy 10, 452, 2008.
13. Kern, S., Eichler, H., Stoeve, J., Kluter, H., and Bieback, K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24, 1294, 2006.
14. Romanov, Y.A., Svintsitskaya, V.A., and Smirnov, V.N. Searching for alternative sources of postnatal human mes-enchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21, 105, 2003.
15. Campagnoli, C., Roberts, I.A., Kumar, S., Bennett, P.R., Bellantuono, I., and Fisk, N.M. Identification of mesenchy-mal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98, 2396, 2001.
16. Zhao, Y., Glesne, D., and Huberman, E. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 100, 2426, 2003.
17. Lund, T.C., Tolar, J., and Orchard, P.J. Granulocyte colony-stimulating factor mobilized CFU-F can be found in the peripheral blood but have limited expansion potential. Haematol Hematol J 93, 908, 2008.
18. Fruehauf, S., Vedwijk, M.R., Seeger, T., Schubert, M., Laufs, S., Topaly, J., Wuchter, P., Dillmann, F., Eckstein, V., Wenz, F., Goldschmidt, H., Ho, A.D., and Calandra, G. A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study. Cytotherapy 11, 992, 2009.
19. Luo, X.J., Chen, B.G., Zheng, R., Lin, P., Li, J.C., and Chen, H.X. Hydrogen peroxide induces apoptosis through the mitochondrial pathway in rat Schwann cells. Neurosci Lett 485, 60, 2010.
20. Dimri, G.P., Lee, X.H., Basile, G., Acosta, M., Scott, C., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Per-eirasmith, O., Peacocke, M., and Campisi, J. A biomarker that identifies senescent human-cells in culture and in aging skin in-vivo. Proc Natl Acad Sci U S A 92, 9363, 1995.
21. Wagner, W., Horn, P., Castoldi, M., Diehlmann, A., Bork, S., Saffrich, R., Benes, V., Blake, J., Pfister, S., Eckstein, V., and Ho, A.D. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3, e2213, 2008.
22. Pusic, I., and DiPersio, J.F. Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Curr Opin Hematol 17, 319, 2010.
23. Chan, J.O., Castanos, R., Jin, Y.S., Kirkman, E.L., Bremner, R.M., Starnes, V.A., and Smith, M.A. Circulating mesen-chymal stem cells are recruited to ischemia-reperfusion injured lungs. J Heart Lung Transpl 27, S176, 2008.
24. Bian, Z.Y., Li, G., Gan, Y.K., Hao, Y.Q., Xu, W.T., and Tang, T.T. Increased number of mesenchymal stem cell-like cells in peripheral blood of patients with bone sarcomas. Arch Med Res 40, 163, 2009.
25. Bruns, C., Conrad, C., Valesky, M., Ischenko, I., Niess, H., Huss, R., Jahn, B., Mojaat, A., Nelson, P., and Jauch, K.W. Homing of circulating mesenchymal stem cells in colon carcinoma liver metastases following liver resection. Onkologie 31, 98, 2008.
26. Carbonare, L.D., Valenti, M.T., Zanatta, M., Donatelli, L., and Lo Cascio, V. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum 60, 3356, 2009.
27. Rochefort, G.Y., Delorme, B., Lopez, A., Herault, O., Bonnet, P., Charbord, P., Eder, V., and Domenech, J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24, 2202, 2006.
28. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Krause, D.S., Deans, R.J., Keating, A., Prockop, D.J., and Horwitz, E.M. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
29. Spees, J.L., Olson, S.D., Ylostalo, J., Lynch, P.J., Smith, J., Perry, A., Peister, A., Wang, M.Y., and Prockop, D.J. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci U S A 100, 2397, 2003.
30. Jaiswal, S., and Weissman, I.L. Hematopoietic stem and progenitor cells and the inflammatory response. Ann N Y Acad Sci 1174, 118, 2009.
31. Kiel, M.J., and Morrison, S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8, 290, 2008.
32. Wilson, A., and Trumpp, A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6, 93, 2006.
33. Damon, L.E., and Damon, L.E. Mobilization of hematopoi-etic stem cells into the peripheral blood. Expert Rev Hematol 2, 717, 2009.
34. Salem, H.K., and Thiemermann, C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28, 585, 2010.
35. Mendez-Ferrer, S., and Frenette, P.S. Hematopoietic stem cell trafficking\-regulated adhesion and attraction to bone marrow microenvironment. Skelet Biol Med Part A 1116, 392, 2007.
36. Bensinger, W., DiPersio, J.F., and McCarty, J.M. Improving stem cell mobilization strategies: future directions. Bone Marrow Transpl 43, 181, 2009.
37. Kessans, M.R., Gatesman, M.L., and Kockler, D.R. Plerixafor: a peripheral blood stem cell mobilizer. Pharmacotherapy 30, 485, 2010.
38. Brave, M., Farrell, A., Lin, S.C., Ocheltree, T., Miksinski, S.P., Lee, S.L., Saber, H., Fourie, J., Tornoe, C., Booth, B., Yuan, W.S., He, K., Justice, R., and Pazdur, R. FDA Review summary: mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation. Oncol Basel 78, 282, 2010.
39. Pitchford, S.C., Furze, R.C., Jones, C.P., Wengner, A.M., and Rankin, S.M. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4, 62, 2009.
40. Han, I., Park, H.J., Seong, S.C., Lee, S., Kim, I.G., and Lee, M.C. Role of transglutaminase 2 in apoptosis induced by hydrogen peroxide in human chondrocytes. J Orthop Res 29, 252, 2011.
41. Zhao, B.C., Zhao, B., Han, J.G., Ma, H.C., and Wang, Z.J. Adipose-derived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis. Hepato Gastroenterol 58, 1382, 2010.
42. Krampera, M., Mosna, F., and Sensebe, L. Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. Stem Cells Dev 19, 1449, 2010.
43. Peault, B., Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P.N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., Buhring, H.J., Giacobino, J.P., Lazzari, L., and Huard, J. A perivascular origin for mesen-chymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
44. Caplan, A.I. All MSCs are pericytes? Cell Stem Cell 3, 229, 2008.
45. Weissman, I.L. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287, 1442, 2000.